Randall Michael Giuffre, Director at DiaMedica Therapeutics Inc. (DMAC), bought 65,000 shares at $3.91 ($254K) on 2023-06-23, disclosed to the SEC on 2023-06-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| DMAC | BUY | 2022-12-05 | $975 | — | Filing → |
| DMAC | BUY | 2022-12-01 | $136K | — | Filing → |
| DMAC | BUY | 2020-11-23 | $64K | — | Filing → |